Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.1600
+0.0100 (6.67%)
Feb 11, 2026, 4:00 PM EST
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $5.41 million as of February 12, 2026. Its market cap has increased by 7.25% in one year.
Market Cap
5.41M
Enterprise Value
22.47M
Revenue
899.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 5.41M, an increase of 2,037.15%. That is a compound annual growth rate of 21.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.57M | 60.00% |
| Dec 31, 2025 | 982.83K | -90.00% |
| Dec 31, 2024 | 9.83M | -38.42% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neon Bloom | 1.85M |
| Carisma Therapeutics | 1.68M |
| Agentix | 1.68M |
| Galera Therapeutics | 1.66M |
| ZyVersa Therapeutics | 1.62M |
| Exousia Pro | 1.54M |
| inTerra Resources | 1.49M |
| International Stem Cell | 1.32M |